AptaBio

News & PR 플랫폼 기술기반 First-in-Class 신약개발 전문 기업

보도자료

[24.07.31] Aptabio Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate ‘APX-343A’ in Combination with KEYTRUDA® (pembrolizumab)

  • 작성일
    2024-08-01 09:40:38
  • 조회수
    2721
  • 추천수
    0